title: Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
authors.forename: N M
authors.initials: NM
authors.lastname: Clark
authors.forename: A
authors.initials: A
authors.lastname: Dieng Sarr
authors.forename: J L
authors.initials: JL
authors.lastname: Sankalé
authors.forename: P J
authors.initials: PJ
authors.lastname: Kanki
authors.forename: P
authors.initials: P
authors.lastname: Kazanjian
authors.forename: R
authors.initials: R
authors.lastname: Winfield
authors.forename: D M
authors.initials: DM
authors.lastname: Markovitz
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004279:DNA, Viral / Q000032:analysis; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015498:HIV-2 / Q000276:immunology*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D011533:Proviruses / Q000235:genetics; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir